Overview

Impact of Ranolazine on Coronary Microcirculatory Resistance

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is being done to determine if Ranolazine treatment improves coronary microcirculation function among patients with coronary microcirculation dysfunction. We are also looking to learn if symptomatic improvement of chest pain during treatment with Ranalozine is related to improved coronary microcirculation function.
Phase:
N/A
Details
Lead Sponsor:
University of New Mexico
Collaborator:
Gilead Sciences
Treatments:
Ranolazine